InvestorsObserver is giving NeoGenomics, Inc. (NEO) an Analyst Rating Rank of 60, meaning NEO is ranked higher by analysts than 60% of stocks. The average price target for NEO is $57.571 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating NEO a Strong Buy today. Find out what this means to you and get the rest of the rankings on NEO!